The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab
The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab is a paper indexed in ScholarIQ from OpenAlex.
How many citations does The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab have?
The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab has 191 citations in the OpenAlex counts ScholarIQ stores.
When was The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab published?
The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab has 2010 year in the ScholarIQ index.
What is the open-access status of The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab?
The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab has hybrid oa status in the ScholarIQ index.
What is the DOI of The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab?
The DOI for The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab is on the source record.
What is the PMID of The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab?
The PMID for The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab is on the source record.
What is the OpenAlex record for The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab?
The OpenAlex for The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab is on the source record.